Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Target: RHOT1
Composite Score: 0.549
Price: $0.55▲55.5%
Citation Quality: Pending
neurodegeneration
Status: proposed
🟢 Parkinson's Disease 🔥 Neuroinflammation 🔴 Alzheimer's Disease 🟡 ALS / Motor Neuron Disease 🧠 Neurodegeneration
✓ All Quality Gates Passed
Quality Report Card click to collapse
C+
Composite: 0.549
Top 67% of 1302 hypotheses
T5 Contested
Contradicted by evidence, under dispute
C+
0.50
Top 77%
C+
0.50
Top 66%
A
0.80
Top 25%
C
0.40
Top 80%
B+
0.70
Top 42%
D
0.30
Top 89%
C+
0.50
Top 59%
A+
0.90
Top 14%
B
0.60
Top 51%
C+
0.50
Top 68%
Evidence
3 supporting
|
3 opposing
Citation quality: 100%
Debates
1 session
A
Avg quality: 0.81
Convergence
1.00
A+
30 related hypothesis share this target
From Analysis:
Mitochondrial transfer between neurons and glia
What are the mechanisms underlying mitochondrial transfer between neurons and glia?
Hypotheses from Same Analysis (6)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Score: 0.559 | Target: GJA1
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor Mitochondria
Score: 0.529 | Target: BNIP3/BNIP3L
Synthetic Biology Approach: Designer Mitochondrial Export Systems
Score: 0.505 | Target: Synthetic fusion proteins
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
Score: 0.482 | Target: RAB27A/LAMP2B
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.476 | Target: ChR2
Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange
Score: 0.436 | Target: PANX1
Description
Small molecule activators of Miro1 GTPase activity increase mitochondrial motility and facilitate intercellular transfer through enhanced organelle mobilization, targeting fundamental transport machinery.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Miro1/RHOT1 Gene"] --> B["Miro1 GTPase on Outer Mitochondrial Membrane"]
B --> C["Milton/TRAK Adaptor Binding"]
C --> D["Kinesin Motor Complex"]
C --> E["Dynein Motor Complex"]
D --> F["Anterograde Transport"]
E --> G["Retrograde Transport"]
F --> H["Mitochondria to Synaptic Terminals"]
G --> I["Damaged Mitochondria to Soma"]
J["Neurodegeneration"] --> K["Miro1 Dysfunction"]
K --> L["Impaired Mitochondrial Trafficking"]
L --> M["Synaptic Energy Deficit"]
L --> N["Failed Mitophagy"]
M --> O["Synaptic Dysfunction"]
N --> P["Damaged Mito Accumulation"]
P --> Q["Oxidative Stress"]
R["Miro1 Enhancement Therapy"] --> S["Restore Miro1-TRAK Interaction"]
S --> T["Normalize Anterograde Transport"]
S --> U["Restore Retrograde Transport"]
T --> V["Synaptic Mitochondrial Supply"]
U --> W["Efficient Damaged Mito Clearance"]
V --> X["Restored Synaptic ATP"]
W --> Y["Reduced ROS"]
X --> Z["Neuroprotection"]
Y --> Z
style J fill:#4a1942,stroke:#ce93d8,color:#e0e0e0
style R fill:#1a3a4a,stroke:#4fc3f7,color:#e0e0e0
style V fill:#1a3a2a,stroke:#81c784,color:#e0e0e0
style Z fill:#2a3a1a,stroke:#c5e1a5,color:#e0e0e0
3D Protein Structure (AlphaFold)
Open full viewerAlphaFold predicted structure available for Q8IXI2
View AlphaFold StructureDimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
6 citations
6 with PMID
Validation: 100%
3 supporting / 3 opposing
✓
For
(3)
(3)
Against
✗
High
Medium
Low
High
Medium
Low
Evidence Matrix
— sortable by strength/year, click Abstract to expand
Evidence Types
MECH 6CLIN 0GENE 0EPID 0
Legacy Card View — expandable citation cards
✓ Supporting Evidence 3
Miro1 controls mitochondrial transport and is essential for intercellular mitochondrial transfer
Miro1 dysfunction contributes to Parkinson's disease pathogenesis
Enhanced Miro1 activity promotes mitochondrial rescue in cellular stress models
✗ Opposing Evidence 3
Miro1 overexpression causes mitochondrial transport defects and cellular stress in neurons
Parkinson's disease involves Miro1 degradation as a protective mechanism to prevent damaged mitochondrial spre…▼
Parkinson's disease involves Miro1 degradation as a protective mechanism to prevent damaged mitochondrial spread
Enhanced mitochondrial motility can increase oxidative stress by disrupting mitochondrial networks
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 5 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
Novel Therapeutic Hypotheses for Mitochondrial Transfer in Neurodegeneration
Hypothesis 1: Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Description: Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons. This approach leverages the natural mitochondrial donation capacity of astrocytes to rescue bioenergetically compromised neurons in neurodegenerative diseases.
Target: Connexin-43 (GJA1 gene)
Supporting Evidence: Astrocytes transfer func
🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Critical Evaluation of Mitochondrial Transfer Hypotheses
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Specific Weaknesses:
- Confounded mechanism: Connexin-43 primarily forms gap junctions for small molecule exchange, not structural tunneling nanotubes for organelle transfer
- Oversimplified pathway: The evidence conflates gap junction communication with physical mitochondrial transfer mechanisms
- Limited therapeutic window: Connexin-43 upregulation could cause seizures and cardiac arrhythmias due to excessive gap junction coupling
Counter-Evidence:
- Connexin
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Practical Feasibility Assessment of Mitochondrial Transfer Hypotheses
Executive Summary
After critical analysis, most hypotheses face significant technical and commercial barriers. Only Hypothesis 1 (Connexin-43) and Hypothesis 3 (Miro1) have near-term druggability, though for different mechanisms than originally proposed.
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Revised Mechanism: Enhanced gap junction-mediated metabolic coupling rather than direct mitochondrial transferDruggability Assessment: MODERATE
Target: Connexin-43 (GJA1) - established⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
7d Trend
↔
Stable
7d Momentum
▼ 0.9%
Volatility
Low
0.0113
Events (7d)
7
⚡ Price Movement Log
Recent 15 events
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| ⚖ | Recalibrated | $0.426 | ▼ 1.3% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.432 | ▲ 1.6% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.425 | ▲ 0.3% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.424 | ▼ 0.8% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.427 | ▲ 0.4% | 2026-04-04 16:02 | |
| ⚖ | Recalibrated | $0.426 | ▼ 13.3% | 2026-04-03 23:46 | |
| 📊 | Score Update | $0.491 | ▼ 45.7% | market_dynamics | 2026-04-03 08:23 |
| 💬 | Debate Round | $0.905 | ▲ 96.4% | market_dynamics | 2026-04-03 07:24 |
| 📄 | New Evidence | $0.461 | ▲ 9.1% | market_dynamics | 2026-04-03 06:03 |
| 💬 | Debate Round | $0.423 | ▼ 32.3% | market_dynamics | 2026-04-03 03:48 |
| 💬 | Debate Round | $0.625 | ▲ 7.4% | market_dynamics | 2026-04-03 03:28 |
| 📊 | Score Update | $0.582 | ▲ 7.8% | market_dynamics | 2026-04-03 02:02 |
| 📄 | New Evidence | $0.540 | ▼ 10.1% | market_dynamics | 2026-04-03 01:40 |
| 📄 | New Evidence | $0.601 | ▼ 2.0% | evidence_batch_update | 2026-04-03 01:06 |
| 📄 | New Evidence | $0.613 | ▼ 5.7% | evidence_batch_update | 2026-04-03 01:06 |
Clinical Trials (5) Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN
·
NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION
·
NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING
·
NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED
·
NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN
·
NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
📚 Cited Papers (35)
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PMID:34285270
8 figures
Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the criteria of the Clinic...
pmc_api
Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium isolates (n = 153). ...
pmc_api
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PMID:33199700
3 figures
Fig. 1
Map of logger deployment sites in Belize.
pmc_api
Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
pmc_api
The Emerging Role of RHOT1/Miro1 in the Pathogenesis of Parkinson's Disease.
Frontiers in neurology (2020) · PMID:33041957
6 figures
Figure 1
The role of Miro1 in mitophagy. (A) Lysosomal degradation of dysfunctional mitochondria requires the stop of mitochondrial transport and detachment from the cytoskeleton. Mitocho...
pmc_api
Figure 2
The role of MERCs in mitophagy and the contribution of PD-associated proteins. (A) Mitophagy also requires the untethering of impaired mitochondria from the ER. Therefore, PINK1 ...
pmc_api
Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss.
Brain : a journal of neurology (2025) · PMID:39913247
6 figures
Figure 1
Parkinson's disease-related pathways were deregulated in p.R272Q Miro1 mutant midbrain organoids and dopaminergic neurons. ( A ) Schematic representation of the in vitro models ...
pmc_api
Figure 2
p.R272Q Miro1 mutation increased ROS and impaired mitochondrial membrane potential in vitro . ( A ) Flow cytometry representation ( left ) and quantification ( right ) of the per...
pmc_api
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PMID:35118419
1 figure
Figures
Figures available at source paper (no open-access XML found).
deep_link
DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking.
Human molecular genetics (2014) · PMID:24092329
No extracted figures yet
Medial prefrontal D1 dopamine neurons control food intake.
Nature neuroscience (2014) · PMID:24441680
No extracted figures yet
Clarithromycin as a chiral selector for enantioseparation of basic compounds in nonaqueous capillary electrophoresis.
Electrophoresis (2014) · PMID:25100556
No extracted figures yet
Genome Sequence of the K139-Like Phage VcP032 Originating from the Vibrio cholerae O1 El Tor Ogawa Serotype.
Genome announcements (2016) · PMID:27445393
No extracted figures yet
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response.
Molecular cancer therapeutics (2019) · PMID:29997151
No extracted figures yet
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
The pharmacogenomics journal (2019) · PMID:30723313
No extracted figures yet
Site-selective and versatile aromatic C-H functionalization by thianthrenation.
Nature (2019) · PMID:30867606
No extracted figures yet
📓 Linked Notebooks (7)
📓 Top 5 Analysis: Sda 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 SciDEX Analysis: 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia — Rich Analysis Notebook
Comprehensive analysis with gene expression, pathway enrichment, and statistical tests for Mitochondrial transfer between neurons and glia
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
Date: 2026-04-02
Domain: neurodegeneration
Hypotheses Generated: 7
Knowledge Graph Edges: 0
Wiki Pages
FER GenegeneNSF ProteinproteinNSF GenegeneNeurodegenerationdiseaseRHOT1 Protein - MIRO1 - Mitochondrial Rho GTPase 1proteinRHOT1 - Mitochondrial Rho GTPase 1geneAlibaba Tongyi Qianwen-Bio (Chinese Biomedical LLMai_toolRHOT1 - Mitochondrial Rho GTPase 1geneRHOT1 Protein - MIRO1 - Mitochondrial Rho GTPase 1proteinAmyotrophic Lateral SclerosisredirectAmyotrophic Lateral Sclerosis (ALS)diseaseBiogencompanyAlzheimer's DiseasediseaseOligodendrocytesredirectMIRO2 Genegene
Related Hypotheses
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
Score: 0.990 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.950 | neurodegeneration
PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction
Score: 0.941 | neurodegeneration
Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Prediction
Score: 0.933 | neurodegeneration
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
Score: 0.921 | neurodegeneration
Estimated Development
Estimated Cost
$850,000
Timeline
2.0 years
🧪 Falsifiable Predictions (4)
4 total
0 confirmed
0 falsified
If hypothesis is true, intervention increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
pending
conf: 0.50
Expected outcome: increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
Falsified by: Intervention fails to increase the formation and stability of these transport complexes, promoting bidirectional mitochondrial movement along microtubules
If hypothesis is true, intervention restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and other intercellular conduits
pending
conf: 0.50
Expected outcome: restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and other intercellular conduits
Falsified by: Intervention fails to restore mitochondrial distribution to energy-demanding regions, improve synaptic mitochondrial content, and facilitate the formation of tunneling nanotubes and other intercellular conduits
If hypothesis is true, intervention facilitate therapeutic mitochondrial exchange
pending
conf: 0.50
Expected outcome: facilitate therapeutic mitochondrial exchange
Falsified by: Intervention fails to facilitate therapeutic mitochondrial exchange
If hypothesis is true, intervention provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions
pending
conf: 0.50
Expected outcome: provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions
Falsified by: Intervention fails to provide transformative treatments for multiple neurodegenerative diseases by targeting a fundamental cellular process affected across pathological conditions
Knowledge Subgraph (0 edges)
No knowledge graph edges recorded
3D Protein Structure
🧬 RHOT1 — PDB 5KSZ Click to expand 3D viewer
Source Analysis
Mitochondrial transfer between neurons and glia
neurodegeneration | 2026-04-01 | completed
Community Feedback
0
0 upvotes · 0 downvotes
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!